Gimsilumab
Gimsilumab (MORAb-022) is a humanized monoclonal antibody targeting granulocyte macrophage colony-stimulating factor for the study of COVID-19-induced inflammation and hypoxemia.
Product Specifications
CAS Number
1648796-29-5
Stability
≥ 2 years
Purity
>98% (HPLC)
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
C-Fms | SARS-CoV
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
40208141 1x 10^6 Cells / 1.0 mL
RNASEH1P1 CRISPR Knock Out 293T Cell Line (Human)
Sign In for Pricing
View Details 
